Tuttiquotidiani is completely free. Every day we aggregate news from 100+ sources and generate original AI summaries for you. Help us keep the service running with a small donation, or become TQ Pro for just €1/month.

Donate now TQ Pro - 1€/mo

Spinal Muscular Atrophy drug: regulatory approval should guide Kerala’s procurement policy, say experts

Posted on June 27, 2026
By The Hindu
0 Views
1 min read

Spinal Muscular Atrophy drug: regulatory approval should guide Kerala’s procurement policy, say experts

Experts urge Kerala to adopt a cost-effective procurement policy for Spinal Muscular Atrophy drugs, prioritizing approved generics over high-priced patents.